The Week In... Nursing + Healthcare (20-24/04)
  • Posted on: 24/04/2020
  • Category: Industry

The Week In... Nursing + Healthcare (20-24/04)

COVID-19: Plasma blood treatment to be trialled, the NIHR and UKRI fund research into COVID-19 infection and immunity in children and teenagers, the RCN hits back at ‘unacceptable’ PPE guidance, and Novartis is to sponsor hydroxychloroquine trials in hospitalised COVID-19 patients.

Interested in Star’s innovative outsourcing and resourcing solutions?

Contact Operations Director, Mark Ward, on 07872 105 540 or email mark.ward@starmedical.co.uk.

On the hunt for a new role, or just curious?

Visit our candidate page, submit your CV to candidates@starmedical.co.uk.

Coronavirus: Plasma treatment to be trialled

The UK is gearing up to use the blood of coronavirus survivors to treat hospital patients ill with the disease.

RCN hits back at ‘unacceptable’ PPE guidance

The Royal College of Nursing has criticised updated guidance from Public Health England on reusing personal protective equipment during severe shortages. 

New research to assess extent of COVID-19 infection in young

The National Institute for Health Research and UK Research and Innovation (UKRI) are funding new research designed to determine rates of coronavirus infection and immunity in children and teenagers across the UK, to help further shape the response to the pandemic.

Coronavirus: Minute's silence in memory of NHS staff

Britain may hold a minute's silence next week to pay tribute to NHS workers who have died with coronavirus.

Novartis sponsors hydroxychloroquine clinical trial in hospitalised COVID-19 patients

Novartis has announced that it is to sponsor a large hydroxychloroquine clinical trial in hospitalised COVID-19 patients.

While you’re here…

…and are interested in our content, why not sign up to our newsletter?

It’s just below.